MicroRNA‑1224 inhibits cell proliferation by downregulating CBX3 expression in chordoma
MicroRNAs (miRNAs/miRs) have abnormal expression in numerous tumors and are closely related to tumor development and resistance to radiotherapy and chemotherapy. However, there are few studies assessing the role and mechanism of miRNA in chordoma. The sequencing data of three pairs of chordoma and n...
Gespeichert in:
Veröffentlicht in: | Oncology letters 2024-06, Vol.27 (6), p.262, Article 262 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 6 |
container_start_page | 262 |
container_title | Oncology letters |
container_volume | 27 |
creator | Xia, Wei Huang, Jihe Sun, Chunhua Shen, Fei Yang, Kejia |
description | MicroRNAs (miRNAs/miRs) have abnormal expression in numerous tumors and are closely related to tumor development and resistance to radiotherapy and chemotherapy. However, there are few studies assessing the role and mechanism of miRNA in chordoma. The sequencing data of three pairs of chordoma and notochord tissues from the GSE56183 dataset were analyzed in the present study. Cell proliferation was assessed
using Cell Counting Kit-8. Bioinformatics analysis and the dual luciferase reporter assay were used to evaluate the regulatory relationship between miR-1224 and chromobox 3 (CBX3) in chordoma. The results demonstrated that miR-1224 had a significantly lower expression level in chordoma tissues and cell lines. Overexpression of miR-1224 inhibited proliferation in the chordoma cells, while the knockdown of miR-1224 promoted proliferation of the chordoma cells. Bioinformatics analysis and the dual luciferase reporter assay confirmed that CBX3 was a direct target gene of miR-1224 and that miR-1224 induced the proliferation of chordoma cells through the inhibition of CBX3. In summary, miR-1224 reduced the proliferation of chordoma cells through inhibition of CBX3, which provides a theoretical basis for selecting a novel therapeutic target for chordoma. |
doi_str_mv | 10.3892/ol.2024.14395 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_3055296669</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A795813887</galeid><sourcerecordid>A795813887</sourcerecordid><originalsourceid>FETCH-LOGICAL-c414t-3f42e3442afe9b6935e0b760304633917434a2c9a1b1f4c37872448ee5e09b1c3</originalsourceid><addsrcrecordid>eNptkU1v1DAQhi1ERau2R64oEhK3LP6YOPZxWZUPqRQJgQQny_FOdl058WIngt74C_xFfgle2q6oxPgw1uiZd-x5CXnK6EIozV_GsOCUw4KB0M0jcsJazWtGFX98uLdwTM5zvqYlGsmUkk_IsVASJGh5Qr6-9y7Fj1fL3z9_Mc6h8uPWd37KlcMQql2KwfeY7OTjWHU31Tp-HxNu5lAq46ZavfoiKvyxS5jznvBj5bYxreNgz8hRb0PG87t8Sj6_vvi0eltffnjzbrW8rB0wmGrRA0cBwG2PupNaNEi7VlJBQQqhWQsCLHfaso714ESrWg6gEAunO-bEKXl-q1ve-m3GPJnrOKexjDSCNg3XUhbVA7WxAY0f-zgl6wafnVm2ulFMKNUWavEfqpw1Dt7FEXtf6g8aXvzTsEUbpm2OYd6vKz8E61uwbDvnhL3ZJT_YdGMYNXsvTQxm76X562Xhn939au4GXB_oe-fEHzzwlnM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3055296669</pqid></control><display><type>article</type><title>MicroRNA‑1224 inhibits cell proliferation by downregulating CBX3 expression in chordoma</title><source>PubMed Central</source><creator>Xia, Wei ; Huang, Jihe ; Sun, Chunhua ; Shen, Fei ; Yang, Kejia</creator><creatorcontrib>Xia, Wei ; Huang, Jihe ; Sun, Chunhua ; Shen, Fei ; Yang, Kejia</creatorcontrib><description>MicroRNAs (miRNAs/miRs) have abnormal expression in numerous tumors and are closely related to tumor development and resistance to radiotherapy and chemotherapy. However, there are few studies assessing the role and mechanism of miRNA in chordoma. The sequencing data of three pairs of chordoma and notochord tissues from the GSE56183 dataset were analyzed in the present study. Cell proliferation was assessed
using Cell Counting Kit-8. Bioinformatics analysis and the dual luciferase reporter assay were used to evaluate the regulatory relationship between miR-1224 and chromobox 3 (CBX3) in chordoma. The results demonstrated that miR-1224 had a significantly lower expression level in chordoma tissues and cell lines. Overexpression of miR-1224 inhibited proliferation in the chordoma cells, while the knockdown of miR-1224 promoted proliferation of the chordoma cells. Bioinformatics analysis and the dual luciferase reporter assay confirmed that CBX3 was a direct target gene of miR-1224 and that miR-1224 induced the proliferation of chordoma cells through the inhibition of CBX3. In summary, miR-1224 reduced the proliferation of chordoma cells through inhibition of CBX3, which provides a theoretical basis for selecting a novel therapeutic target for chordoma.</description><identifier>ISSN: 1792-1074</identifier><identifier>EISSN: 1792-1082</identifier><identifier>DOI: 10.3892/ol.2024.14395</identifier><identifier>PMID: 38646496</identifier><language>eng</language><publisher>Greece: Spandidos Publications</publisher><subject>Analysis ; Biotechnology ; Cancer ; Cell growth ; Chemotherapy ; Datasets ; Design ; Genes ; Health aspects ; Luciferase ; MicroRNA ; MicroRNAs ; Plasmids ; Proteins ; Radiation therapy ; Scientific equipment and supplies industry ; Software ; Tumors ; Tumors, Embryonal</subject><ispartof>Oncology letters, 2024-06, Vol.27 (6), p.262, Article 262</ispartof><rights>Copyright: © 2024 Xia et al.</rights><rights>COPYRIGHT 2024 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2024</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c414t-3f42e3442afe9b6935e0b760304633917434a2c9a1b1f4c37872448ee5e09b1c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27928,27929</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38646496$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xia, Wei</creatorcontrib><creatorcontrib>Huang, Jihe</creatorcontrib><creatorcontrib>Sun, Chunhua</creatorcontrib><creatorcontrib>Shen, Fei</creatorcontrib><creatorcontrib>Yang, Kejia</creatorcontrib><title>MicroRNA‑1224 inhibits cell proliferation by downregulating CBX3 expression in chordoma</title><title>Oncology letters</title><addtitle>Oncol Lett</addtitle><description>MicroRNAs (miRNAs/miRs) have abnormal expression in numerous tumors and are closely related to tumor development and resistance to radiotherapy and chemotherapy. However, there are few studies assessing the role and mechanism of miRNA in chordoma. The sequencing data of three pairs of chordoma and notochord tissues from the GSE56183 dataset were analyzed in the present study. Cell proliferation was assessed
using Cell Counting Kit-8. Bioinformatics analysis and the dual luciferase reporter assay were used to evaluate the regulatory relationship between miR-1224 and chromobox 3 (CBX3) in chordoma. The results demonstrated that miR-1224 had a significantly lower expression level in chordoma tissues and cell lines. Overexpression of miR-1224 inhibited proliferation in the chordoma cells, while the knockdown of miR-1224 promoted proliferation of the chordoma cells. Bioinformatics analysis and the dual luciferase reporter assay confirmed that CBX3 was a direct target gene of miR-1224 and that miR-1224 induced the proliferation of chordoma cells through the inhibition of CBX3. In summary, miR-1224 reduced the proliferation of chordoma cells through inhibition of CBX3, which provides a theoretical basis for selecting a novel therapeutic target for chordoma.</description><subject>Analysis</subject><subject>Biotechnology</subject><subject>Cancer</subject><subject>Cell growth</subject><subject>Chemotherapy</subject><subject>Datasets</subject><subject>Design</subject><subject>Genes</subject><subject>Health aspects</subject><subject>Luciferase</subject><subject>MicroRNA</subject><subject>MicroRNAs</subject><subject>Plasmids</subject><subject>Proteins</subject><subject>Radiation therapy</subject><subject>Scientific equipment and supplies industry</subject><subject>Software</subject><subject>Tumors</subject><subject>Tumors, Embryonal</subject><issn>1792-1074</issn><issn>1792-1082</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNptkU1v1DAQhi1ERau2R64oEhK3LP6YOPZxWZUPqRQJgQQny_FOdl058WIngt74C_xFfgle2q6oxPgw1uiZd-x5CXnK6EIozV_GsOCUw4KB0M0jcsJazWtGFX98uLdwTM5zvqYlGsmUkk_IsVASJGh5Qr6-9y7Fj1fL3z9_Mc6h8uPWd37KlcMQql2KwfeY7OTjWHU31Tp-HxNu5lAq46ZavfoiKvyxS5jznvBj5bYxreNgz8hRb0PG87t8Sj6_vvi0eltffnjzbrW8rB0wmGrRA0cBwG2PupNaNEi7VlJBQQqhWQsCLHfaso714ESrWg6gEAunO-bEKXl-q1ve-m3GPJnrOKexjDSCNg3XUhbVA7WxAY0f-zgl6wafnVm2ulFMKNUWavEfqpw1Dt7FEXtf6g8aXvzTsEUbpm2OYd6vKz8E61uwbDvnhL3ZJT_YdGMYNXsvTQxm76X562Xhn939au4GXB_oe-fEHzzwlnM</recordid><startdate>20240601</startdate><enddate>20240601</enddate><creator>Xia, Wei</creator><creator>Huang, Jihe</creator><creator>Sun, Chunhua</creator><creator>Shen, Fei</creator><creator>Yang, Kejia</creator><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20240601</creationdate><title>MicroRNA‑1224 inhibits cell proliferation by downregulating CBX3 expression in chordoma</title><author>Xia, Wei ; Huang, Jihe ; Sun, Chunhua ; Shen, Fei ; Yang, Kejia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c414t-3f42e3442afe9b6935e0b760304633917434a2c9a1b1f4c37872448ee5e09b1c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Analysis</topic><topic>Biotechnology</topic><topic>Cancer</topic><topic>Cell growth</topic><topic>Chemotherapy</topic><topic>Datasets</topic><topic>Design</topic><topic>Genes</topic><topic>Health aspects</topic><topic>Luciferase</topic><topic>MicroRNA</topic><topic>MicroRNAs</topic><topic>Plasmids</topic><topic>Proteins</topic><topic>Radiation therapy</topic><topic>Scientific equipment and supplies industry</topic><topic>Software</topic><topic>Tumors</topic><topic>Tumors, Embryonal</topic><toplevel>online_resources</toplevel><creatorcontrib>Xia, Wei</creatorcontrib><creatorcontrib>Huang, Jihe</creatorcontrib><creatorcontrib>Sun, Chunhua</creatorcontrib><creatorcontrib>Shen, Fei</creatorcontrib><creatorcontrib>Yang, Kejia</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Oncology letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xia, Wei</au><au>Huang, Jihe</au><au>Sun, Chunhua</au><au>Shen, Fei</au><au>Yang, Kejia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MicroRNA‑1224 inhibits cell proliferation by downregulating CBX3 expression in chordoma</atitle><jtitle>Oncology letters</jtitle><addtitle>Oncol Lett</addtitle><date>2024-06-01</date><risdate>2024</risdate><volume>27</volume><issue>6</issue><spage>262</spage><pages>262-</pages><artnum>262</artnum><issn>1792-1074</issn><eissn>1792-1082</eissn><abstract>MicroRNAs (miRNAs/miRs) have abnormal expression in numerous tumors and are closely related to tumor development and resistance to radiotherapy and chemotherapy. However, there are few studies assessing the role and mechanism of miRNA in chordoma. The sequencing data of three pairs of chordoma and notochord tissues from the GSE56183 dataset were analyzed in the present study. Cell proliferation was assessed
using Cell Counting Kit-8. Bioinformatics analysis and the dual luciferase reporter assay were used to evaluate the regulatory relationship between miR-1224 and chromobox 3 (CBX3) in chordoma. The results demonstrated that miR-1224 had a significantly lower expression level in chordoma tissues and cell lines. Overexpression of miR-1224 inhibited proliferation in the chordoma cells, while the knockdown of miR-1224 promoted proliferation of the chordoma cells. Bioinformatics analysis and the dual luciferase reporter assay confirmed that CBX3 was a direct target gene of miR-1224 and that miR-1224 induced the proliferation of chordoma cells through the inhibition of CBX3. In summary, miR-1224 reduced the proliferation of chordoma cells through inhibition of CBX3, which provides a theoretical basis for selecting a novel therapeutic target for chordoma.</abstract><cop>Greece</cop><pub>Spandidos Publications</pub><pmid>38646496</pmid><doi>10.3892/ol.2024.14395</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1792-1074 |
ispartof | Oncology letters, 2024-06, Vol.27 (6), p.262, Article 262 |
issn | 1792-1074 1792-1082 |
language | eng |
recordid | cdi_proquest_journals_3055296669 |
source | PubMed Central |
subjects | Analysis Biotechnology Cancer Cell growth Chemotherapy Datasets Design Genes Health aspects Luciferase MicroRNA MicroRNAs Plasmids Proteins Radiation therapy Scientific equipment and supplies industry Software Tumors Tumors, Embryonal |
title | MicroRNA‑1224 inhibits cell proliferation by downregulating CBX3 expression in chordoma |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T12%3A34%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MicroRNA%E2%80%911224%20inhibits%20cell%20proliferation%20by%20downregulating%20CBX3%20expression%20in%20chordoma&rft.jtitle=Oncology%20letters&rft.au=Xia,%20Wei&rft.date=2024-06-01&rft.volume=27&rft.issue=6&rft.spage=262&rft.pages=262-&rft.artnum=262&rft.issn=1792-1074&rft.eissn=1792-1082&rft_id=info:doi/10.3892/ol.2024.14395&rft_dat=%3Cgale_proqu%3EA795813887%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3055296669&rft_id=info:pmid/38646496&rft_galeid=A795813887&rfr_iscdi=true |